{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:46:48Z","timestamp":1790063208705,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.cardfail.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T12:03:12Z","timestamp":1492516992000},"page":"517-524","source":"Crossref","is-referenced-by-count":23,"title":["Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a \u201cPure\u201d Patient Phenotype and the Generalizability of Trial Findings"],"prefix":"10.1016","volume":"23","author":[{"given":"Hitesh C.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Dungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Saidmeerasah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesan","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Cowie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2017.04.006_bib0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/eurjhf\/hfp103","article-title":"The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis","volume":"11","author":"Somaratne","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0020","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The Perindopril In Elderly People With Chronic Heart Failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0025","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0030","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Origasa","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","author":"Ferrari","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0055","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurheartj\/ehu067","article-title":"Heart failure with preserved ejection fraction: a clinical dilemma","volume":"35","author":"Komajda","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0065","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/eurheartj\/ehu204","article-title":"New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes","volume":"35","author":"Senni","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2013.10.006","article-title":"Developing therapies for heart failure with preserved ejection fraction: current state and future directions","volume":"2","author":"Butler","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0075","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2013.07.010","article-title":"Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter","volume":"62","author":"Shah","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0080","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2015.03.043","article-title":"Patient selection in heart failure with preserved ejection fraction clinical trials","volume":"65","author":"Kelly","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ejhf.106","article-title":"Heart failure with preserved ejection fraction: the impact of stricter definitions","volume":"16","author":"Patel","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0090","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.eurheartj.a015339","article-title":"The treatment of heart failure","volume":"18","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0110","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0115","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/euhj.1998.1057","article-title":"How to diagnose diastolic heart failure","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0125","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/jama.2010.1592","article-title":"Age disparities in heart failure research","volume":"304","author":"Kitzman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11739-008-0180-9","article-title":"Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice","volume":"4","author":"Costantino","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0135","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT)","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0145","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(12)61349-X","article-title":"Heart failure\u2014does it matter whether LVEF is reduced?","volume":"380","author":"Cleland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0150","doi-asserted-by":"crossref","first-page":"e003866","DOI":"10.1136\/bmjopen-2013-003866","article-title":"Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey","volume":"4","author":"Hancock","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bmj.326.7382.196","article-title":"Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study","volume":"326","author":"Fuat","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1388-9842(02)00119-8","article-title":"Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners","volume":"4","author":"Khunti","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0165","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.115.019902","article-title":"Good clinical practice guidance and pragmatic clinical trials: balancing the best of both worlds","volume":"133","author":"Mentz","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrcardio.2015.33","article-title":"Registry-based randomized clinical trials\u2013a new clinical trial paradigm","volume":"12","author":"James","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2017.04.006_bib0180","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","article-title":"Thrombus aspiration during ST-segment elevation myocardial infarction","volume":"369","author":"Frobert","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916417300994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916417300994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T12:24:58Z","timestamp":1535891098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916417300994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1071916417300994"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2017.04.006","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}